Import substitution of microspheres; overturning the table
2024-11-08
With the full-scale centralized procurement initiative underway, the price of biochemical reagents has plummeted, presenting a significant new challenge for domestic manufacturers—intense cost reduction pressure!
*Image source: Internet
But don't worry, we have the resourceful and intelligent ally, "Litop Microsphere"! It won't let domestic manufacturers fight alone; instead, it has introduced the "import substitution" strategy, determined to help reduce costs drastically!
Taking CRP as an example, the cost of imported microspheres was previously a significant portion of the total cost, accounting for 73.2%, which was alarming. However, with the introduction of Litop Microspheres, this proportion has dramatically decreased to 4.3%, resulting in a cost reduction of 72%! Coupled with a single-batch production capacity of 200L and minimal batch-to-batch variation, Litop Microspheres deserves high praise.
Therefore, with Litop Microspheres as the "cost reduction master," domestic manufacturers can now rest assured and confidently compete.
There are two cooperation models
Service Hotline
Address: Building C6, Nanjing Life Science and Technology Innovation Park
Email:marketing@leadingmed.com
Website:www.leadingmed.cn
WeChat Business Consultation
Copyright © All Rights Reserved: Nanjing Leading Medical Technology Co., Ltd.